<DOC>
	<DOCNO>NCT00617318</DOCNO>
	<brief_summary>Pomegranate long history use folk medicine . There vast data health benefit pomegranate fruit juice . Multiple study establish strong antioxidative effect pomegranate polyphenols ( primarily ellagitannin punicalagin ) health effect . A vast number animal human clinical study provide evidence effect pomegranate product improve blood lipid profile , reduce blood pressure , improve endothelial function , anti-tumor activity , anti-atherosclerotic activity . We study protective effect pomegranate concentrate ( POM Flu Cold Formula® ) decrease incidence duration influenza-like illness common cold among healthy adult .</brief_summary>
	<brief_title>Pomegranate Products Prevention Common Cold</brief_title>
	<detailed_description>Pomegranate long history use folk medicine . Widely grow consumed country , pomegranate fruit product produce use extensively US . The health benefit pomegranate fruit juice substantiate much research , include multiple study show beneficial antioxidative effect pomegranate polyphenols ( primarily ellagitannin punicalagin ) . Both vitro vivo study demonstrate pomegranate product provide hepatoprotection toxin , reduce tumor cell growth , anti-angiogenesis , immunomodulatory , free-radical scavenging effect . Furthermore , animal clinical study indicate pomegranate product improve blood lipid profile , reduce blood pressure , enhance endothelial function , provide anti-tumor anti-atherosclerotic activity . No adverse event report clinical study 300 human subject consume 8 fluid ounce ( oz ) POM Wonderful® ( POM LLC , Los Angeles , CA ) pomegranate juice daily period long 3 year . These clinical trial include sensitive subpopulation , patient atherosclerotic disease , diabetes , hypertension , prostate cancer . Moreover , serious adverse effect report human , animal vitro study publish date . Ex vivo laboratory study show pomegranate polyphenols considerable antioxidant activity . Because importance oxidative stress influenza infection complication , previously assess anti-influenza effect pomegranate product ex vivo study ( See accompany manuscript ) . Our laboratory finding show anti-influenza , virucidal effect pomegranate product lead u study clinical effect influenza common cold human volunteer . Previous study show effect natural product incidence course influenza infection . The purpose current study ass effect pomegranate concentrate ( POM Flu Cold Formula , POM Wonderful LLC , Los Angeles , CA ) prevent symptom influenza common cold influenza season . POM Flu Cold Formula intend oral use provide supplemental antioxidant healthy population .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Common Cold</mesh_term>
	<criteria>Subjects must meet inclusion criterion order eligible participate study : Subject must able read sign Informed Consent Form ( ICF ) . Subject must male female &gt; 21 &lt; 49 year age time ICF sign . Subject must make personal decision NOT receive influenza vaccine season . A subject meeting exclusion criterion baseline exclude study participation : Subject know allergy pomegranate POM product . Subject intercurrent infection fever week investigational product administration begin . Subject experience acute respiratory tract infection , otitis medium , bronchitis sinusitis , treated antiviral drug , systemic steroid , immunosuppressant within two week Screening/Randomization Visit . Subject uncontrolled chronic medical disorder ( e.g. , subject evidence evolve hepatic renal failure , congestive heart failure Killip Class IV , terminal disease ) . Subject report HIV infection . Subject abuse alcohol drug abuse . Subject clinical evidence current malignancy . Female subject positive pregnancy test , sexually active use adequate contraception regularly , nurse mother . Subject take experimental product within one month prior study entry . Subject medical condition may interfere study protocol adherence . Subject disorder ( exclude illiteracy visual impairment ) compromise ability subject give write informed consent and/or comply study procedure . Subject opinion study investigator risk noncompliance study procedure , read , understand complete study related material . Subject foreseeable inability complete schedule followup . Subject meet one criterion influenza immunization accord current CDC List Priority Groups Vaccination .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>Pomegranate</keyword>
	<keyword>Influenza</keyword>
	<keyword>Common Cold</keyword>
	<keyword>Cough</keyword>
	<keyword>Severity</keyword>
	<keyword>Efficacy</keyword>
</DOC>